期刊文献+
共找到11篇文章
< 1 >
每页显示 20 50 100
Comparisons between glucose analogue 2-deoxy-2-(^(18)F)fluoro-D-glucose and ^(18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions 被引量:3
1
作者 Selene Capitanio Francesca Bongioanni +13 位作者 Arnoldo Piccardo Claudio Campus Roberta Gonella Lucia Tixi Mehrdad Naseri Michele Pennone Vania Altrinetti Ambra Buschiazzo Irene Bossert Francesco Fiz Andrea Bruno Andrea DeCensi Gianmario Sambuceti Silvia Morbelli 《World Journal of Radiology》 CAS 2016年第2期200-209,共10页
AIM: To compare 2-deoxy-2-(^(18)F)fluoro-D-glucose(^(18)FFDG) and ^(18)F-sodium(^(18)F-NaF) positron emission tomography/computed tomography(PET/CT) accuracy in breast cancer patients with clinically/radiologically su... AIM: To compare 2-deoxy-2-(^(18)F)fluoro-D-glucose(^(18)FFDG) and ^(18)F-sodium(^(18)F-NaF) positron emission tomography/computed tomography(PET/CT) accuracy in breast cancer patients with clinically/radiologically suspected or known bone metastases.METHODS: A total of 45 consecutive patients with breast cancer and the presence or clinical/biochemical or radiological suspicion of bone metastatic disease underwent ^(18)F-FDG and ^(18)F-fluoride PET/CT. Imaging results were compared with histopathology when available, or clinical and radiological follow-up of at least 1 year. For each technique we calculated: Sensitivity(Se), specificity(Sp), overall accuracy, positive and negative predictive values, error rate, and Youden's index. Mc Nemar's χ~2 test was used to test the difference in sensitivity and specificity between the two diagnostic methods. All analyses were computed on a patient basis, and then on a lesion basis, with consideration ofthe density of independent lesions on the coregistered CT(sclerotic, lytic, mixed, no-lesions) and the divergent site of disease(skull, spine, ribs, extremities, pelvis). The impact of adding ^(18)F-Na F PET/CT to the work-up of patients was also measured in terms of change in their management due to ^(18)F-Na F PET/CT findings. RESULTS: The two imaging methods of ^(18)F-FDG and ^(18)F-fluoride PET/CT were significantly different at the patient-based analysis: Accuracy was 86.7% and 84.4%, respectively(Mc Nemar's χ~2 = 6.23, df = 1, P = 0.01). Overall, 244 bone lesions were detected in our analysis. The overall accuracy of the two methods was significantly different at lesion-based analysis(Mc Nemar's χ~2 = 93.4, df = 1, P < 0.0001). In the lesion density-based and site-based analysis, ^(18)F-FDG PET/CT provided more accurate results in the detection of CT-negative metastasis(P < 0.002) and vertebral localizations(P < 0.002); ^(18)F-Na F PET/CT was more accurate in detecting sclerotic(P < 0.005) and rib lesions(P < 0.04). ^(18)F-Na F PET/CT led to a change of management in 3 of the 45 patients(6.6%) by revealing findings that were not detected at ^(18)F-FDG PET/CT. CONCLUSION: ^(18)F-FDG PET/CT is a reliable imaging tool in the detection of bone metastasis in most cases, with a diagnostic accuracy that is slightly, but significantly, superior to that of ^(18)F-Na F PET/CT in the general population of breast cancer patients. However, the extremely high sensitivity of ^(18)F-fluoride PET/CT can exploit its diagnostic potential in specific clinical settings(i.e., small CT-evident sclerotic lesions, high clinical suspicious of relapse, and negative ^(18)F-FDG PET and conventional imaging). 展开更多
关键词 18f-sodium positron emission tomography/ computed TOMOGRAPHY Breast cancer Bone lesion 2-deoxy-2-(18F)fluoro-D-glucose
下载PDF
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 被引量:2
2
作者 Francesco Fiz Silvia Morbelli +8 位作者 Matteo Bauckneht Arnoldo Piccardo Giulia Ferrarazzo Alberto Nieri Nathan Artom Manlio Cabria Cecilia Marini Marco Canepa Gianmario Sambuceti 《World Journal of Radiology》 CAS 2016年第1期82-89,共8页
AIM: To investigating the relationship between thoracic and cardiac 18F-Natrium-Fluoride(18F-Na F) uptake,as a marker of ongoing calcification and cardiovascular risk factors.METHODS: Seventy-eight patients(44 females... AIM: To investigating the relationship between thoracic and cardiac 18F-Natrium-Fluoride(18F-Na F) uptake,as a marker of ongoing calcification and cardiovascular risk factors.METHODS: Seventy-eight patients(44 females,mean age 63,range 44-83) underwent whole body 18F-Na F positron emission tomography/computed tomography. Cardiovascular risk(CVR) was used to divide these patients in three categories: Low(LR),medium(MR) and high risk(HR). 18F-Na F uptake was measured by manually drawing volumes of interest on the ascendingaorta,on the aortic arch,on the descending aorta and on the myocardium; average standardized uptake value was normalized for blood-pool,to obtain target-tobackground ratio(TBR). Values from the three aortic segments were then averaged to obtain an index of the whole thoracic aorta.RESULTS: A significant difference in whole thoracic aorta TBR was detected between HR and LR(1.84 ± 0.76 vs 1.07 ± 0.3,P < 0.001),but also between MR and HR-LR(1.4 ± 0.4,P < 0.02 and P < 0.01,respectively). Significance of this TBR stratification strongly varied among thoracic aorta subsegments and the lowest P values were reached in the descending aorta(P < 0.01). Myocardial uptake provided an effective CVR classes stratification(P < 0.001).Correlation between TBR and CVR was appreciable when the whole thoracic aorta was considered(R = 0.67),but it peaked when correlating the descending thoracic segment(R = 0.75),in comparison with the aortic arch and the ascending segment(R = 0.55 and 0.53,respectively). CONCLUSION: Fluoride uptake within the thoracic aorta wall effectively depicts patients' risk class and correlates with cardiovascular risk. Descending aorta is the most effective in CVR determination. 展开更多
关键词 POSITRON emission tomography/computed tomography 18F-Natrium fluoride PLAQUE imaging Cardiovascular risk profile THORACIC AORTA
下载PDF
PET显像剂^18F-NaF骨骼分布的实验研究 被引量:2
3
作者 王鹏 李钦宗 王明芳 《南方医科大学学报》 CAS CSCD 北大核心 2008年第1期76-78,共3页
目的探讨18F-NaF在骨质疏松症实验研究中的应用价值。方法用过量地塞米松磷酸钠注射法制作大鼠骨质疏松模型,对动物模型注射18F-NaF,进行生物分布研究,测定大鼠各器官对18F-NaF的摄取值。对8例健康志愿者进行胸部动态及全身PET显像,测... 目的探讨18F-NaF在骨质疏松症实验研究中的应用价值。方法用过量地塞米松磷酸钠注射法制作大鼠骨质疏松模型,对动物模型注射18F-NaF,进行生物分布研究,测定大鼠各器官对18F-NaF的摄取值。对8例健康志愿者进行胸部动态及全身PET显像,测定骨骼对18F-NaF的摄取。结果骨质疏松大鼠骨骼对18F-NaF的摄取值低于对照组,其中实验组股骨颈、腰椎、第七肋骨及胫骨对18F-NaF的摄取明显低于对照组(P<0.05);健康志愿者胸部动态PET显像发现,在注射后20s,脊柱骨、肱骨、肋骨有明显的18F-NaF摄取,随着时间的延长,骨骼对18F-NaF的摄取逐渐增加,60min摄取达峰值。60min行全身PET显像发现,全身骨骼明显摄取18F-NaF,骨骼/肌肉比值高,平均为8.12。结论18F-NaF是理想的骨血流和代谢显像剂,18F-NaF在正常骨和实验性骨质疏松症骨骼中的分布有明显差异,提示18F-NaF在骨质疏松症的研究中具有潜在应用价值。 展开更多
关键词 ^18F-NaF 生物分布 正电子发射计算机断层显像 骨质疏松症
下载PDF
骨骼显像剂^(18)F-NaF的制备及生物分布研究
4
作者 范文博 《山东化工》 CAS 2022年第22期55-57,61,共4页
研究^(18)F-NaF注射液的制备方法及其动物体内生物分布,利用^([18])O(p,n)18F核反应,经直接处理法制备18-NaF注射液,测定其在小鼠体内的生物分布。用30μA的质子束流连续轰击^([18])O-H_(2)O 50 min后,^(18)F-NaF的平均产额(EOS)为800 G... 研究^(18)F-NaF注射液的制备方法及其动物体内生物分布,利用^([18])O(p,n)18F核反应,经直接处理法制备18-NaF注射液,测定其在小鼠体内的生物分布。用30μA的质子束流连续轰击^([18])O-H_(2)O 50 min后,^(18)F-NaF的平均产额(EOS)为800 GBq;^(18)F-NaF注射液的放射性浓度均大于74.0 GBq/mL,产物经TLC测定,放射化学纯度大于90%。小鼠生物分布实验显示注射后骨骼对^(18)F-NaF的摄取率最高,平均为84.1%;注射10 min后,骨骼/血液、骨骼/肌肉比值大于10;注射后90 min,骨骼与肌肉的比值最高,与60 min和120 min的比值相比有显著性差异(均为P<0.05)。注射后10 min,约有19.8%的^(18)F-NaF经肾脏排泄到膀胱中,60 min后经肾脏排泄的^(18)F-NaF平均为2.2%;其他器官放射性均相对较低。直接处理法是简单有效的制备方法,制备^(18)FNaF注射液生物性能稳定、安全。^(18)F-NaF的骨骼/肌肉比值高,是理想的骨血流和代谢显像剂。在注射^(18)F-NaF后90 min进行PET骨显像可获得清晰的图像。 展开更多
关键词 ^(18)F-NaF注射液 正电子药物 生物分布
下载PDF
Na18F PET/CT用于恶性肿瘤骨转移诊断的Meta分析 被引量:12
5
作者 郭飞虎 成伟华 +4 位作者 费月英 徐晓敏 吴建爽 阚英 杨吉刚 《标记免疫分析与临床》 CAS 2019年第5期786-794,836,共10页
目的Na^18F是一种主要用于诊断成骨反应活性程度增加的骨疾病的正电子计算机断层显像药物,肿瘤骨转移的诊断是其重要的适应症之一。本研究旨在对Na18FPET/CT用于肿瘤骨转移诊断的诊断效果进行系统评价。方法对2000年1月1日至2018年12月3... 目的Na^18F是一种主要用于诊断成骨反应活性程度增加的骨疾病的正电子计算机断层显像药物,肿瘤骨转移的诊断是其重要的适应症之一。本研究旨在对Na18FPET/CT用于肿瘤骨转移诊断的诊断效果进行系统评价。方法对2000年1月1日至2018年12月31日公开发表的Na^18F PET/CT诊断骨转移的文献用计算机检索中英文数据库,根据纳入与排除标准筛选出符合要求的文献,进行数据提取和质量评价,采用Stata 12.00软件进行Meta分析。结果共35篇文献纳入本研究,中文文献9篇,英文文献26篇。Meta分析结果显示:①Na^18F PET/CT诊断骨转移的灵敏度、特异性、阳性似然比、阴性似然比、曲线下面积,以患者为计算基础时分别为0.97、0.93、14.5、0.03和0.99;以病灶为计算基础时分别为0.96、0.88、8.3、0.05和0.98;②对不同原发灶(肺癌、乳腺癌及前列腺癌)的ROC曲线比较可知:三种不同的原发灶之间均无显著性差异;③所有纳入本研究的文献未见有使用Na18F后出现不良反应的报道。结论无论以患者还是以病灶为基础,Na^18F PET/CT诊断骨转移的效能均很好,Na^18F PET/CT对肺癌、乳腺癌和前列腺癌骨转移的诊断效能无明显差异,未见使用Na18F后出现不良反应的报道。 展开更多
关键词 正电子计算机断层显像 氟(18F)化钠 肿瘤 骨转移 META分析
下载PDF
18 F-NaF PET/CT与99m Tc-MDP骨显像诊断乳腺癌骨转移瘤的对比研究 被引量:4
6
作者 倪明 汪世存 +1 位作者 谢强 张洪波 《医学影像学杂志》 2020年第9期1648-1652,共5页
目的对比分析18 F标记的氟化钠(18 F-Fluoride,18 F-NaF)PET/CT骨显像与99m Tc标记的亚甲基二膦酸盐(99m Tc-MDP)骨显像(bone scintigraphy,BS)对诊断乳腺癌骨转移的临床价值。方法回顾性分析经病理证实为乳腺癌且临床怀疑骨转移的48例... 目的对比分析18 F标记的氟化钠(18 F-Fluoride,18 F-NaF)PET/CT骨显像与99m Tc标记的亚甲基二膦酸盐(99m Tc-MDP)骨显像(bone scintigraphy,BS)对诊断乳腺癌骨转移的临床价值。方法回顾性分析经病理证实为乳腺癌且临床怀疑骨转移的48例女性患者,在1周内分别行18 F-NaF PET/CT骨显像与BS检查,以病理学或临床随访结果为诊断依据,分别在病例和病灶水平上比较两种检查方法的诊断效能。结果48例乳腺癌患者经证实38例、147个病灶为骨转移瘤。在病例水平上,18 F-NaF PET/CT与BS显示骨转移瘤的检出率及特异度间的差异无统计学意义(P=0.210,P=0.582),18 F-NaF PET/CT显示骨转移瘤的灵敏度高于BS(P<0.01),18 F-NaF PET/CT发现乳腺癌骨转移瘤的效能与标准组高度一致(Kappa=0.934,μ=14.369,P<0.01),而BS发现乳腺癌骨转移瘤的效能与标准组中等一致(Kappa=0.413,μ=2.888,P<0.05)。在病灶水平上,18 F-NaF PET/CT发现骨转移灶的检出率、灵敏度、特异度和符合率均高于BS(χ^2=9.892,χ^2=23.263,χ^2=9.028,χ^2=30.897,P<0.01),18 F-NaF PET/CT发现乳腺癌骨转移灶的效能与标准组高度一致(Kappa=0.881,μ=16.942,P<0.01),而BS发现乳腺癌骨转移灶的效能与标准组一致性差(Kappa=0.238,μ=2.674,P<0.05)。结论18 F-NaF PET/CT骨显像对乳腺癌骨转移的诊断效能总体优于BS,具有一定的临床指导意义和应用价值。 展开更多
关键词 乳腺癌 18 F标记的氟化钠 骨转移 骨显像 正电子发射断层成像/计算机断层成像
下载PDF
氟[^(18)F]化钠PET/CT临床应用进展 被引量:1
7
作者 董瑞林 李光 +6 位作者 徐晓敏 吴建爽 高菲 张文辉 宋志浩 张蕴瀚 成伟华 《标记免疫分析与临床》 CAS 2022年第3期522-528,共7页
氟[^(18)F]化钠(^(18)F-NaF)是一种正电子发射计算机断层显像(PET)药物,主要用于诊断成骨性反应活跃的骨疾病,尤其是恶性肿瘤骨转移的诊断。由于药物本身的特性以及PET/CT相对于单光子发射计算机断层显像(SPECT)/CT的优势,^(18)F-NaF PE... 氟[^(18)F]化钠(^(18)F-NaF)是一种正电子发射计算机断层显像(PET)药物,主要用于诊断成骨性反应活跃的骨疾病,尤其是恶性肿瘤骨转移的诊断。由于药物本身的特性以及PET/CT相对于单光子发射计算机断层显像(SPECT)/CT的优势,^(18)F-NaF PET/CT显像相比于^(99)Tc-^(m)亚甲基二膦酸盐(^(99)Tc^(m)-MDP)SPECT/CT具有高灵敏度和高特异性的特点,能更早发现SPECT/CT不能探测到的病灶。这对肿瘤治疗方案的选择和预后判断具有重要的临床意义。另外,氟[^(18)F]化钠也能够有效鉴别具有破裂高风险的冠状动脉粥样硬化斑块。本文就^(18)F-NaF PET/CT在多种骨骼疾病诊断中的应用作一综述。 展开更多
关键词 氟[^(18)F]化钠 骨显像剂 骨转移 正电子计算机断层显像
下载PDF
PET-CT技术诊断骨质疏松症的实验研究 被引量:7
8
作者 李钦宗 田明波 +1 位作者 汪青春 谢秋萍 《中国骨质疏松杂志》 CAS CSCD 2006年第4期401-404,共4页
目的应用正电子发射计算机体层摄影设备(PETCT)对18FNaF进行药代动力学研究,探讨18FNaF对骨质疏松模型动物的摄取机理,为诊断骨质疏松症提供理论依据。方法用切除卵巢法制作大鼠骨质疏松模型,对动物模型注射18FNaF,利用PETCT对各组大鼠... 目的应用正电子发射计算机体层摄影设备(PETCT)对18FNaF进行药代动力学研究,探讨18FNaF对骨质疏松模型动物的摄取机理,为诊断骨质疏松症提供理论依据。方法用切除卵巢法制作大鼠骨质疏松模型,对动物模型注射18FNaF,利用PETCT对各组大鼠进行全身显像,测定各骨骼对18FNaF的摄取值。对比切卵巢实验组与对照组大鼠摄取18FNaF的值,并进行统计学分析。结果切卵巢实验组主要骨骼对18FNaF的摄取值低于对照组,两组数据差异有统计学意义。结论18FNaF是理想的骨血流和代谢显像剂,以18FNaF作为显像剂的PETCT技术对诊断骨质疏松症具有较高的诊断价值。 展开更多
关键词 ^18F-NaF 生物分布 正电子发射计算机体层摄影-CT 骨质疏松症 动物模型
下载PDF
冠醚催化合成香豆素 被引量:6
9
作者 周成栋 谢国龙 《湘潭大学自然科学学报》 CAS CSCD 1993年第3期87-90,共4页
在固-液相转移催化条件下,以二苯并-18-冠-6(DB18C6)为相转移催化剂,甲苯为溶剂,对于以氟化钾催化剂合成香豆素有增催化作用,使产率从64.4%提高到78.8%,反应时间缩短,最佳摩尔比为水杨醛∶乙酐∶氟化钾∶DB18C6=1∶3.1∶0.7∶0.05。
关键词 香豆素 相转移催化 冠醚 DB18C6
下载PDF
复配相转移催化体系催化的芳香化合物卤素交换氟化反应 被引量:1
10
作者 朱含 罗晓燕 《华东理工大学学报(自然科学版)》 CAS CSCD 北大核心 2017年第2期203-206,共4页
卤素交换氟化反应是制备芳香氟化物的重要方法,在工业生产中得到了广泛的应用。以四苯基溴化膦(x=5%)和18-冠-6/(x=1%)为复配相转移催化剂,成功实现了单卤素或多卤素取代的芳香化合物氟化反应,收率最高可达92%。该方法具有催化剂用量低... 卤素交换氟化反应是制备芳香氟化物的重要方法,在工业生产中得到了广泛的应用。以四苯基溴化膦(x=5%)和18-冠-6/(x=1%)为复配相转移催化剂,成功实现了单卤素或多卤素取代的芳香化合物氟化反应,收率最高可达92%。该方法具有催化剂用量低、底物范围较宽等优点。 展开更多
关键词 卤素交换氟化反应 相转移催化剂 四苯基溴化膦 18-冠-6
下载PDF
Nuclear medicine and the failed joint replacement: Past, present, and future 被引量:6
11
作者 Christopher J Palestro 《World Journal of Radiology》 CAS 2014年第7期446-458,共13页
Soon after the introduction of the modern prosthetic joint,it was recognized that radionuclide imaging provides useful information about these devices.The bone scan was used extensively to identify causes of prostheti... Soon after the introduction of the modern prosthetic joint,it was recognized that radionuclide imaging provides useful information about these devices.The bone scan was used extensively to identify causes of prosthetic joint failure.It became apparent,however,that although sensitive,regardless of how the images were analyzed or how it was performed,the test was not specific and could not distinguish among the causes of prosthetic failure.Advances in anatomic imaging,notably cross sectional modalities,have facilitated the diagnosis of many,if not most,causes of prosthetic failure,with the important exception of infection.This has led to a shift in the diagnostic paradigm,in which nuclear medicine investigations increasingly have focused on diagnosing infection.The recognition that bone scintigraphy could not reliably diagnose infection led to the development of combined studies,first bone/gallium and subsequently leukocyte/bone and leukocyte/marrow imaging.Labeled leukocyte imaging,combined with bone marrow imaging is the most accurate(about90%)imaging test for diagnosing joint arthroplasty infection.Its value not withstanding,there are significant disadvantages to this test.In-vivo techniques for labeling leukocytes,using antigranulocyte antibodieshave been explored,but have their own limitations and the results have been inconsistent.Fluorodeoxyglucose(FDG)-positron emission tomography(FDG-PET)has been extensively investigated for more than a decade but its role in diagnosing the infected prosthesis has yet to be established.Antimicrobial peptides bind to bacterial cell membranes and are infection specific.Data suggest that these agents may be useful for diagnosing prosthetic joint infection,but large scale studies have yet to be undertaken.Although for many years nuclear medicine has focused on diagnosing prosthetic joint infection,the advent of hybrid imaging with singlephoton emission computed tomography(SPECT)/electronic computer X-ray tomography technique(CT)and the availability of fluorine-18 fluoride PET suggests that the diagnostic paradigm may be shifting again.By providing the anatomic information lacking in conventional radionuclide studies,there is renewed interest in bone scintigraphy,performed as a SPECT/CT procedure,for detecting joint instability,mechanical loosening and component malpositioning.Fluoride-PET may provide new insights into periprosthetic bone metabolism.The objective of this manuscript is to provide a comprehensive review of the evolution of nuclear medicine imaging of joint replacements. 展开更多
关键词 Bone SCINTIGRAPHY POSITRON EMISSION TOMOGRAPHY 18F-FLUORODEOXYGLUCOSE F-18 fluoride-positron EMISSION TOMOGRAPHY Gallium Infection Labeled leukocytes Prosthetic joint
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部